尚品宅配(300616.SZ):收到深交所中止審核通知
格隆匯8月21日丨尚品宅配(300616.SZ)公佈,公司向特定對象發行股票申請於2021年12月29日獲得深交所受理,並於2022年5月23日收到深交所出具的《關於廣州尚品宅配家居股份有限公司申請向特定對象發行股票的第二輪審核問詢函》(以下簡稱"第二輪審核問詢函"),公司會同相關中介機構於2022年5月30日按要求對第二輪審核問詢函進行了回覆。
公司為此次發行聘請的保薦機構因其為其他公司提供的服務被中國證監會立案調查,根據《深圳證券交易所創業板上市公司證券發行上市審核規則》第十九條、《深圳證券交易所創業板股票發行上市審核規則》第六十四條的相關規定,深交所於2022年8月19日決定中止此次發行的審核。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.